Dr Allison Jeynes-Ellis, a research and development specialist in oncology has been appointed the ABPI’s new medical and innovation director.
She takes over from Dr Richard Tiner, who is retiring after 13 years as the ABPI’s medical director. The job title has changed to reflect the broader remit of the new role, which will see Dr Jeynes-Ellis drive forward the ABPI’s innovation agenda.
This remit covers R&D, manufacturing, regulation and medical affairs, representing the whole spectrum from first discovery through to approval of new medicines.
A graduate of Sheffield University, Dr Jeynes-Ellis moved into the pharmaceutical sector after working in hospital medicine. She has spent 17 years in the industry in a variety of senior roles, including six years as medical director for Wyeth UK. Before Wyeth she was director of oncology at Bristol Myers Squibb. She currently works as an independent consultant, working for large and small pharmaceutical companies and within the biotech sector.
No comments:
Post a Comment